FDA Approved: PREGABALIN CAPSULES, CV — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s supplemental application for Pregabalin Capsules, CV, enabling the marketing of a generic pregabalin capsule product (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Fibromyalgia
• Generalized Anxiety Disorder
• Partial-onset Seizures
• Postherpetic Neuralgia

Drugs mentioned

• Pregabalin Capsules, CV (pregabalin)

Snippet

SUPPL AP for PREGABALIN CAPSULES, CV (PREGABALIN CAPSULES, CV)